United States · FDA National Drug Code directory
Talicia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57841-1150_0649301c-fc4e-42a4-a62d-9a023a3f9f98
- Product NDC
- 57841-1150
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- omeprazole magnesium, amoxicillin and rifabutin
- Labeler
- RedHill Biopharma Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200309
- Source listing expiry
- 20261231
Source-listed ingredients
- OMEPRAZOLE MAGNESIUM — 10 mg/1
- AMOXICILLIN — 250 mg/1
- RIFABUTIN — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 CARTON (57841-1150-2) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-1) · 57841-1150-2
- 2 BOTTLE in 1 CARTON (57841-1150-4) / 84 CAPSULE, DELAYED RELEASE in 1 BOTTLE (57841-1150-3) · 57841-1150-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →